CIK 0001447362
- Accelerated filer
CASTLE BIOSCIENCES INC
Sign in to watch- Ticker
- CSTL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770701774
- Phone
- +1 866-788-9007
- Business address
- 1500 W. PARKWOOD AVE., SUITE 400, FRIENDSWOOD, TX, 77546
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,055,183
- in 19 filings, $5.1M under 10b5-1 plans
Net −$6,055,183. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 57 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −3,198 | $35.57 | $114K | 8,038 |
| 2026-10-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −2,718 | $35.57 | $97K | 6,832 |
| 2026-10-01 | Oelschlager Kristen M Chief Operating Officer | Sale 10b5-1 | −2,807 | $35.75 | $100K | 14,702 |
| 2026-10-01 | Oelschlager Kristen M Chief Operating Officer | Sale 10b5-1 | −1,346 | $36.38 | $49K | 13,356 |
| 2026-09-30 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −1,034 | $34.20 | $35K | 52,007 |
| 2026-09-29 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −5,543 | $35.50 | $197K | 53,041 |
| 2026-09-21 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −8,580 | $35.33 | $303K | 21,479 |
| 2026-09-21 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −3,198 | $35.33 | $113K | 11,236 |
| 2026-09-21 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −2,718 | $35.33 | $96K | 9,550 |
| 2026-09-15 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −3,294 | $35.14 | $116K | 58,584 |
| 2026-09-14 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −3,306 | $32.32 | $107K | 61,878 |
| 2026-09-11 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −8,361 | $32.00 | $268K | 21,702 |
| 2026-09-11 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −3,124 | $32.00 | $100K | 14,517 |
| 2026-09-11 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −2,656 | $32.00 | $85K | 12,339 |
| 2026-09-11 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −223 | $32.78 | $7K | 21,479 |
| 2026-09-11 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −83 | $32.78 | $3K | 14,434 |
| 2026-09-11 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −71 | $32.78 | $2K | 12,268 |
| 2026-09-01 | Oelschlager Kristen M Chief Operating Officer | Sale 10b5-1 | −3,952 | $33.36 | $132K | 13,556 |
| 2026-09-01 | Oelschlager Kristen M Chief Operating Officer | Sale 10b5-1 | −200 | $34.02 | $7K | 13,356 |
| 2026-08-31 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −1,730 | $32.81 | $57K | 65,184 |
Page 2 of 116 · 2,303 trades